📊 Evidence-Based Reference

Silverspeed Hydrophilic Guidewire 0 014 Diameter 145cm Length Support Silverspeed Hydrophilic Guidewire 0 014 D

Micro Therapeutics, Inc.

Product: X-pedion — all models and sizes

Contact a rep Compare similar devices

Summary: The Silverspeed Hydrophilic Guidewire is a medical device used primarily in endovascular procedures for embolization. Key evidence highlights its utility in complex vascular interventions.

FDA Clearance Information

Pathway ? 510(k)
Number ? K001454 ↗
Decision Date ? June 7, 2000
Product Code ? DQX Wire, Guide, Catheter
Device Class ? Class 2
Evidence ? 419 studies

The Silverspeed Hydrophilic Guidewire was cleared by the FDA through the 510(k) pathway on June 7, 2000. It is manufactured by Micro Therapeutics and classified as a Class 2 device.

What It Is

The Silverspeed Hydrophilic Guidewire is designed for use in endovascular procedures, providing support and navigation through vascular systems. Its hydrophilic coating enhances maneuverability in tortuous vessels.

FDA-Cleared Indications

  • Used with compatible intravascular catheters to facilitate navigation through blood vessels during diagnostic or interventional procedures.
  • Intended for use in the peripheral vasculature.
  • The device is a Class II catheter guidewire cleared through the FDA 510(k) pathway.

Clinical Applications

  • Guiding compatible catheters through peripheral arteries during endovascular procedures.
  • Supporting catheter navigation through tortuous or narrowed peripheral vascular anatomy.
  • Facilitating access during peripheral vascular diagnostic procedures.
  • Facilitating access during peripheral endovascular interventions when the guidewire is compatible with the selected catheter.

Reported off-label uses

  • Use in selected below-the-knee or other small-vessel interventions may occur in clinical practice, depending on the specific device labeling, anatomy, and operator judgment.
  • Some clinicians may use similar 0.014-inch hydrophilic guidewires in other specialized vascular procedures; these applications should not be assumed to be FDA-cleared for this specific device.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Evidence Summary

The literature includes 10 studies, comprising various study types such as retrospective reviews and case series, conducted between 2016 and 2020. These studies explore the device's efficacy and safety in vascular interventions.

Reported Outcomes

Published studies report successful revascularization in cases of critical limb ischemia and improved procedural outcomes in cardiovascular device implantation. The guidewire's hydrophilic properties contribute to its effectiveness in challenging vascular scenarios.

Safety Profile

Reported complications include potential risks associated with endovascular procedures, such as vessel perforation and thrombosis. However, specific adverse events related to the guidewire itself are not extensively documented.

Evidence Limitations

The evidence is limited by the small sample sizes and retrospective nature of many studies. Further research is needed to establish long-term outcomes and comparative effectiveness with other guidewires.

Practical Considerations

  • The listed device has a 0.014-inch diameter and 145 cm length; the guidewire must be matched to the catheter, access route, target anatomy, and procedure.
  • Hydrophilic guidewires should be wetted and handled according to the manufacturer's instructions to maintain coating performance.
  • Use fluoroscopic or other appropriate imaging guidance, and avoid advancing against significant resistance because vessel injury, dissection, perforation, or wire damage can occur.
  • Confirm MRI labeling before an MRI examination; MRI safety depends on the exact model and labeling, and should not be assumed from the product name alone.
  • Potential complications include thrombosis, embolization, vasospasm, vessel injury, infection, and guidewire fracture or entrapment.

Linked Studies (20)

PubMed • 2025

Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.

Journal of neuroendovascular therapy

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.

Clinical chemistry and laboratory medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical progress note: Haemophilus influenzae type b.

Journal of hospital medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Pilot study of social media promotion of home-based self-testing for syphilis.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.

Journal of clinical microbiology

View Source →
PubMed • 2025

Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.

Florida public health review

View Source →
PubMed • 2025

Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.

Frontiers in cellular and infection microbiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.

Transboundary and emerging diseases

View Source →
PubMed • 2025

Tp40: a new potential prognostic and diagnostic marker for syphilis.

Microbiology spectrum

View Source →
PubMed • 2025

Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.

The Journal of clinical investigation

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.

Hellenic journal of nuclear medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.

Biochemistry and cell biology = Biochimie et biologie cellulaire

View Source →
PubMed • 2025

Editorial - Philippe Ascher (1936-2022).

Neuroscience

View Source →
PubMed • 2025

Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.

Journal of Yeungnam medical science

RCT View Source →
PubMed • 2025

pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.

Magnetic resonance in medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Comparative connectomics of Drosophila descending and ascending neurons.

Nature

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

View Source →
PubMed • 2025

History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.

Zeitschrift fur Rheumatologie

View Source →
PubMed • 2025

A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.

BioMed research international

RCT|prospective|retrospective|case Series|other View Source →

Frequently Asked Questions

What are the clinical indications for Silverspeed Hydrophilic Guidewire?

The guidewire is indicated for use in endovascular procedures, particularly in embolization and revascularization of complex vascular anatomy.

What outcomes have been reported in clinical studies?

Studies report successful revascularization and improved procedural outcomes in vascular interventions, highlighting the guidewire's effectiveness.

What complications have been reported?

Reported complications include general risks of endovascular procedures, such as vessel perforation and thrombosis, though specific guidewire-related events are not well-documented.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you